NCI launches trial to assess the utility of genetic sequencing to improve patient outcomes

A pilot trial to assess whether assigning treatment based on specific gene mutations can provide benefit to patients with metastatic solid tumors is being launched this month by the National Cancer Institute , part of the National Institutes of Health.

http://ift.tt/1fl6tgb